vs
MADRIGAL PHARMACEUTICALS, INC.(MDGL)与Stitch Fix, Inc.(SFIX)财务数据对比。点击上方公司名可切换其他公司
Stitch Fix, Inc.的季度营收约是MADRIGAL PHARMACEUTICALS, INC.的1.1倍($342.1M vs $321.1M),Stitch Fix, Inc.净利率更高(-1.9% vs -18.2%,领先16.4%),MADRIGAL PHARMACEUTICALS, INC.同比增速更快(210.8% vs 7.3%),Stitch Fix, Inc.自由现金流更多($5.6M vs $-133.8M)
本公司是一家美国生物制药企业,成立于2002年,专注于研发新型合成胆汁酸类似物,可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病,以及胆汁酸性腹泻等肠道疾病。
Stitch Fix是美国的在线个人造型服务平台,依托推荐算法与数据科学技术,根据顾客的身形尺寸、预算和风格偏好推送个性化服饰单品。该公司创立于2011年,2017年完成首次公开募股,目前总部位于旧金山。
MDGL vs SFIX — 直观对比
营收规模更大
SFIX
是对方的1.1倍
$321.1M
营收增速更快
MDGL
高出203.5%
7.3%
净利率更高
SFIX
高出16.4%
-18.2%
自由现金流更多
SFIX
多$139.4M
$-133.8M
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $321.1M | $342.1M |
| 净利润 | $-58.6M | $-6.4M |
| 毛利率 | — | 43.6% |
| 营业利润率 | -18.6% | -2.5% |
| 净利率 | -18.2% | -1.9% |
| 营收同比 | 210.8% | 7.3% |
| 净利润同比 | 1.4% | -1.7% |
| 每股收益(稀释后) | $-2.55 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
MDGL
SFIX
| Q4 25 | $321.1M | $342.1M | ||
| Q3 25 | $287.3M | $311.2M | ||
| Q2 25 | $212.8M | $325.0M | ||
| Q1 25 | $137.3M | $312.1M | ||
| Q4 24 | $103.3M | $318.8M | ||
| Q3 24 | $62.2M | $319.6M | ||
| Q2 24 | — | $322.7M | ||
| Q1 24 | $0 | $330.4M |
净利润
MDGL
SFIX
| Q4 25 | $-58.6M | $-6.4M | ||
| Q3 25 | $-114.2M | $-8.6M | ||
| Q2 25 | $-42.3M | $-7.4M | ||
| Q1 25 | $-73.2M | $-6.5M | ||
| Q4 24 | $-59.4M | $-6.3M | ||
| Q3 24 | $-107.0M | $-36.5M | ||
| Q2 24 | — | $-21.3M | ||
| Q1 24 | $-147.5M | $-35.5M |
毛利率
MDGL
SFIX
| Q4 25 | — | 43.6% | ||
| Q3 25 | — | 43.6% | ||
| Q2 25 | — | 44.2% | ||
| Q1 25 | 96.7% | 44.5% | ||
| Q4 24 | — | 45.4% | ||
| Q3 24 | — | 44.6% | ||
| Q2 24 | — | 45.5% | ||
| Q1 24 | — | 43.4% |
营业利润率
MDGL
SFIX
| Q4 25 | -18.6% | -2.5% | ||
| Q3 25 | -39.7% | -3.6% | ||
| Q2 25 | -22.2% | -3.0% | ||
| Q1 25 | -57.8% | -2.9% | ||
| Q4 24 | -64.8% | -2.8% | ||
| Q3 24 | -187.1% | -13.1% | ||
| Q2 24 | — | -7.7% | ||
| Q1 24 | — | -11.5% |
净利率
MDGL
SFIX
| Q4 25 | -18.2% | -1.9% | ||
| Q3 25 | -39.8% | -2.8% | ||
| Q2 25 | -19.9% | -2.3% | ||
| Q1 25 | -53.4% | -2.1% | ||
| Q4 24 | -57.5% | -2.0% | ||
| Q3 24 | -172.0% | -11.4% | ||
| Q2 24 | — | -6.6% | ||
| Q1 24 | — | -10.8% |
每股收益(稀释后)
MDGL
SFIX
| Q4 25 | $-2.55 | $-0.05 | ||
| Q3 25 | $-5.08 | $-0.06 | ||
| Q2 25 | $-1.90 | $-0.06 | ||
| Q1 25 | $-3.32 | $-0.05 | ||
| Q4 24 | $-2.50 | $-0.05 | ||
| Q3 24 | $-4.92 | $-0.29 | ||
| Q2 24 | — | $-0.18 | ||
| Q1 24 | $-7.38 | $-0.30 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $198.7M | $244.2M |
| 总债务越低越好 | $339.9M | — |
| 股东权益账面价值 | $602.7M | $204.1M |
| 总资产 | $1.3B | $530.7M |
| 负债/权益比越低杠杆越低 | 0.56× | — |
8季度趋势,按日历期对齐
现金及短期投资
MDGL
SFIX
| Q4 25 | $198.7M | $244.2M | ||
| Q3 25 | $295.7M | $234.9M | ||
| Q2 25 | $186.2M | $234.2M | ||
| Q1 25 | $183.6M | $219.1M | ||
| Q4 24 | $100.0M | $253.3M | ||
| Q3 24 | $232.7M | $247.0M | ||
| Q2 24 | — | $244.5M | ||
| Q1 24 | $622.5M | $229.8M |
总债务
MDGL
SFIX
| Q4 25 | $339.9M | — | ||
| Q3 25 | $339.8M | — | ||
| Q2 25 | $118.4M | — | ||
| Q1 25 | $118.0M | — | ||
| Q4 24 | $117.6M | — | ||
| Q3 24 | $117.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $116.1M | — |
股东权益
MDGL
SFIX
| Q4 25 | $602.7M | $204.1M | ||
| Q3 25 | $625.7M | $203.0M | ||
| Q2 25 | $696.0M | $200.4M | ||
| Q1 25 | $710.6M | $197.8M | ||
| Q4 24 | $754.4M | $190.5M | ||
| Q3 24 | $777.2M | $187.0M | ||
| Q2 24 | — | $208.9M | ||
| Q1 24 | $850.8M | $213.3M |
总资产
MDGL
SFIX
| Q4 25 | $1.3B | $530.7M | ||
| Q3 25 | $1.4B | $480.6M | ||
| Q2 25 | $1.0B | $484.7M | ||
| Q1 25 | $996.6M | $472.6M | ||
| Q4 24 | $1.0B | $507.1M | ||
| Q3 24 | $1.1B | $486.9M | ||
| Q2 24 | — | $537.0M | ||
| Q1 24 | $1.1B | $538.3M |
负债/权益比
MDGL
SFIX
| Q4 25 | 0.56× | — | ||
| Q3 25 | 0.54× | — | ||
| Q2 25 | 0.17× | — | ||
| Q1 25 | 0.17× | — | ||
| Q4 24 | 0.16× | — | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.14× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-133.5M | $10.9M |
| 自由现金流经营现金流 - 资本支出 | $-133.8M | $5.6M |
| 自由现金流率自由现金流/营收 | -41.7% | 1.6% |
| 资本支出强度资本支出/营收 | 0.1% | 1.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $4.9M |
8季度趋势,按日历期对齐
经营现金流
MDGL
SFIX
| Q4 25 | $-133.5M | $10.9M | ||
| Q3 25 | $79.8M | $7.0M | ||
| Q2 25 | $-47.1M | $20.5M | ||
| Q1 25 | $-88.9M | $-16.2M | ||
| Q4 24 | $-104.5M | $14.3M | ||
| Q3 24 | $-67.0M | $8.2M | ||
| Q2 24 | — | $21.7M | ||
| Q1 24 | $-149.2M | $-22.3M |
自由现金流
MDGL
SFIX
| Q4 25 | $-133.8M | $5.6M | ||
| Q3 25 | $79.0M | $2.8M | ||
| Q2 25 | — | $16.0M | ||
| Q1 25 | — | $-19.4M | ||
| Q4 24 | $-104.7M | $9.9M | ||
| Q3 24 | $-67.8M | $4.5M | ||
| Q2 24 | — | $18.9M | ||
| Q1 24 | $-149.5M | $-26.1M |
自由现金流率
MDGL
SFIX
| Q4 25 | -41.7% | 1.6% | ||
| Q3 25 | 27.5% | 0.9% | ||
| Q2 25 | — | 4.9% | ||
| Q1 25 | — | -6.2% | ||
| Q4 24 | -101.3% | 3.1% | ||
| Q3 24 | -109.0% | 1.4% | ||
| Q2 24 | — | 5.9% | ||
| Q1 24 | — | -7.9% |
资本支出强度
MDGL
SFIX
| Q4 25 | 0.1% | 1.6% | ||
| Q3 25 | 0.3% | 1.4% | ||
| Q2 25 | 0.0% | 1.4% | ||
| Q1 25 | 0.0% | 1.0% | ||
| Q4 24 | 0.2% | 1.4% | ||
| Q3 24 | 1.3% | 1.2% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | — | 1.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |
SFIX
暂无分部数据